Skip to content
Subscriber Only

Theranos Gets Additional Week to Respond to U.S. Inspection

  • Blood-test startup has hired new director for California lab
  • Regulators had ordered changes at lab, threatened sanctions
Updated on

Blood-testing startup Theranos Inc. said it has been given a one-week extension by U.S. regulators to say how it will fix flaws at a California laboratory.

Deficiencies at Theranos’s lab in Newark, California, “pose immediate jeopardy to patient health and safety,” officials at the U.S. Centers for Medicare and Medicaid Services said in a Jan. 25 letter. At the time, the agency demanded immediate changes at the lab and threatened the closely held company with sanctions. Theranos, which was given 10 days to respond, has hired a new lab director, Kingshuk Das.